药明生物（02269）今日盘中大涨6.10%，引起市场广泛关注。这一涨幅或与近期南向资金持续流入有关。
据悉，在4月1日大涨前的交易日（3月31日），南向资金增持药明生物730.71万股，这已经是连续第三个交易日增持该股。截至3月31日收盘，港股通共持有药明生物117311.15万股，占流通股28.56%。这表明内地投资者对药明生物保持着较强的信心。
值得注意的是，药明生物近期表现抢眼。数据显示，该股近5个交易日上涨2.66%，港股通累计增持1289.94万股；近20个交易日更是大涨20.76%，期间港股通累计增持1982.89万股。南向资金的持续买入可能进一步推动了今日的股价上涨。投资者应密切关注该股后市表现，但同时也要注意股市风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.